CoviCept Therapeutics
About:
CoviCept Therapeutics is focused on the development of a small molecule that inhibits the replication and spread of RNA viruses.
Top Investors: Forbion Capital Partners
Description:
CoviCept Therapeutics is focused on the development of a small molecule that inhibits the replication and spread of RNA viruses.
Total Funding Amount:
$2.3M
Headquarters Location:
San Diego, California, United States
Founded Date:
2020-01-01
Founders:
Jeffrey Esko, Philip Gordts, Sam Tsimikas
Number of Employees:
1-10
Last Funding Date:
2021-01-19
IPO Status:
Private
Industries:
© 2025 bioDAO.ai